Provectus Biopharmaceuticals Inc. Reports First Quarter Financial Results

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT,, a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”), today announced its results of operations and financial condition for the first quarter ended March 31, 2015.

Provectus will also hold its quarterly business update conference call at 4 p.m. (EDT) today to provide a business update on PV-10 and PH-10 to the investment community and answer questions from investors.

Help employers find you! Check out all the jobs and post your resume.

Back to news